Randomized clinical trial of the efficacy and safety of insulin glargine vs. NPH insulin as basal insulin for the treatment of glucocorticoid induced hyperglycemia using continuous glucose monitoring in hospitalized patients with type 2 diabetes and respiratory disease
- 1 November 2015
- journal article
- research article
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 110 (2) , 158-165
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Efficacy of a basal bolus insulin protocol to treat prednisolone‐induced hyperglycaemia in hospitalised patientsInternal Medicine Journal, 2015
- Hyperglycemia Induced by Glucocorticoids in Nondiabetic Patients: A Meta-AnalysisAnnals of Nutrition and Metabolism, 2014
- Glucocorticoid‐induced hyperglycemia (糖皮质激素诱导的高血糖)Journal of Diabetes, 2013
- Management of Hyperglycemia in Diabetic Patients with Hematologic Malignancies During Dexamethasone TherapyEndocrine Practice, 2013
- Management of Hyperglycemia in Hospitalized Patients in Non-Critical Care Setting: An Endocrine Society Clinical Practice GuidelineThe Journal of Clinical Endocrinology & Metabolism, 2012
- Pharmacokinetics and Pharmacodynamics of Therapeutic Doses of Basal Insulins NPH, Glargine, and Detemir After 1 Week of Daily Administration at Bedtime in Type 2 Diabetic SubjectsDiabetes Care, 2011
- Randomized Study of Basal-Bolus Insulin Therapy in the Inpatient Management of Patients With Type 2 Diabetes Undergoing General Surgery (RABBIT 2 Surgery)Diabetes Care, 2011
- Glucocorticoid-Induced HyperglycemiaEndocrine Practice, 2009
- Use of Continuous Glucose Monitoring to Estimate Insulin Requirements in Patients with Type 1 Diabetes Mellitus during a Short Course of PrednisoneJournal of Diabetes Science and Technology, 2008
- Randomized Study of Basal-Bolus Insulin Therapy in the Inpatient Management of Patients With Type 2 Diabetes (RABBIT 2 Trial)Diabetes Care, 2007